Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Medical Ikkou Co Ltd (3353)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,553.0 0.0    0.00%
01/05 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3921040006 
  • Volume: 0
  • Bid/Ask: 2,475.0 / 2,570.0
  • Day's Range: 2,553.0 - 2,580.0
Medical Ikkou 2,553.0 0.0 0.00%

3353 Balance Sheet

 
Featured here, the Balance Sheet for Medical Ikkou Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2024
29/02
2023
30/11
2023
31/08
2023
31/05
Total Current Assets 16722 18099 13982 13747
Cash and Short Term Investments 7700 7811 6739 6651
Cash - - - -
Cash & Equivalents 7700 7811 6739 6651
Short Term Investments - - - -
Total Receivables, Net 6058 7392 5436 5182
Accounts Receivables - Trade, Net 6058 7392 5436 5182
Total Inventory 1752 1809 1298 1253
Prepaid Expenses - - - -
Other Current Assets, Total 1212 1087 509 661
Total Assets 31659 32765 28480 28081
Property/Plant/Equipment, Total - Net 9116 9439 9535 9561
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net 692 1161 1198 1246
Intangibles, Net 168 170 179 180
Long Term Investments 4495 3895 3585 3346
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 1 1 1
Other Assets, Total -2630 -4496 -3629 -3268
Total Current Liabilities 10404 12197 7894 7960
Accounts Payable 5231 5229 3754 3686
Payable/Accrued - - - -
Accrued Expenses 276 28 251 408
Notes Payable/Short Term Debt 1345 2810 190 200
Current Port. of LT Debt/Capital Leases 2349 2397 2539 2611
Other Current liabilities, Total 1203 1733 1160 1055
Total Liabilities 17819 19362 15391 15380
Total Long Term Debt 5883 5712 6249 6247
Long Term Debt 5717 5541 6072 6065
Capital Lease Obligations 166 171 177 182
Deferred Income Tax - - - -
Minority Interest 600 593 583 570
Other Liabilities, Total -413 -1950 475 203
Total Equity 13840 13403 13089 12701
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 917 917 917 917
Additional Paid-In Capital 1081 1081 1081 1081
Retained Earnings (Accumulated Deficit) 11447 11204 10927 10694
Treasury Stock - Common -537 -537 -537 -539
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 932 738 701 548
Total Liabilities & Shareholders' Equity 31659 32765 28480 28081
Total Common Shares Outstanding 3.76 3.76 3.76 3.76
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

3353 Comments

Write your thoughts about Medical Ikkou Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email